Eli Lilly (NYSE:LLY) announced today that it entered a definitive agreement to acquire biopharmaceutical company Sigilon. Cambridge, Massachusetts-based Sigilon seeks to develop functional cures for patients with a range of acute and chronic diseases. The two companies have collaborated since 2018 to develop encapsulated cell therapies, including SIG-002. These therapies aim to treat type 1 […]
Ypsomed to expand drug delivery device manufacturing, add 200 jobs
Ypsomed announced today that, at its annual general meeting, its shareholders approved all proposals, including facility expansions. Burgdorf, Switzerland-based Ypsomed develops drug delivery devices, including insulin pumps for those with diabetes. Its YpsoPump represents a leading offering as an automated insulin delivery system compatible with certain software and glucose monitors. Board member Simon Michel confirmed […]
PharmaJet Tropis becomes exclusive intradermal delivery system for two COVID-19 vaccines
PharmaJet announced that its Tropis system is now the exclusive intradermal delivery system for two novel COVID-19 vaccines. Golden, Colorado-based PharmaJet engineers precision delivery systems that overcome the challenges of nucleic acid vaccine delivery. Its Tropis system now offers the delivery of the world’s first plasmid DNA COVID-19 vaccine from Zydus Lifesciences. Exclusively delivered with […]
Study shows health equity impact from Virta Health diabetes reversal platform
Virta Health announced that real-world data for its diabetes reversal platform demonstrated narrowing gaps in care. The company shared its data at the American Diabetes Association’s 83rd Scientific Sessions. The research highlighted its impact on health equity. It demonstrated significant health improvement and medication reduction for members in the most and least disadvantaged U.S. neighborhoods. […]
Vida Health reports positive data for virtual diabetes program in low-income populations
Vida Health announced new research demonstrating significantly lowered A1C levels with its virtual cardiometabolic program. The research highlighted use of the program in low-income Medicare Advantage members. Significantly lowered A1C levels even occurred in areas with limited income and food access. Vida Health’s study compared its members living in areas of low income and low […]
Sernova reports positive interim data for Cell Pouch System
Sernova today announced positive interim data from the clinical trial of its Cell Pouch System in patients with type 1 diabetes. London, Ontario-based Sernova designed its proprietary Cell Pouch System as an implantable and scalable medical device. It forms a natural environment in the body for the long-term survival and function of therapeutic cells. Those […]
Studies back Fractyl Health diabetes reversal procedure, gene therapy
Fractyl Health announced multiple studies supporting its programs for the reversal and treatment of diabetes. Lexington, Massachusetts-based Fractyl reported data from its Revitalize 1 pivotal study and its Rejuva program. Revitalize 1 evaluates the company’s Revita endoscopic ablation procedure to reverse diabetes. Rejuva evaluates a targeted pancreatic gene therapy. The company presented its results at […]
Data supports safety and accuracy of Senseonics 365-day CGM
Senseonics (NYSE:SENS) today announced positive clinical data highlighting the effectiveness of its Eversense continuous glucose monitor (CGM). Germantown, Maryland-based Senseonics presented two studies on its latest-generation Eversense E3 at the American Diabetes Association 83rd Scientific Session. The 180-day implantable CGM received FDA approval in February of last year. The sensor is fully implantable and requires just […]
Once-weekly insulin from Novo Nordisk meets clinical trial endpoints
Novo Nordisk announced data that met primary endpoints from clinical trials investigating its once-weekly basal insulin icodec. While meeting primary endpoints, the studies also demonstrated reduced injections. These injections decreased from seven to one per week with once-daily basal insulin. Novo Nordisk presented results at the 83rd Annual Scientific Sessions of the American Diabetes Association […]
Abbott, ADA partner on therapeutic nutrition program for people with diabetes
Abbott (NYSE:ABT) and the American Diabetes Association (ADA) announced a collaboration to improve nutrition for people with diabetes. The duo aims to help better understand how diabetes technology, like continuous glucose monitoring (CGM), can help. They hope to aid people with diabetes make more informed decisions about their food and activity. Abbott develops a family […]